Federal Court Blocks Medicare Advantage Audits, Raising Oversight Concerns

A recent ruling by a U.S. District Court in Texas invalidated a Biden-era Department of Health and Human Services (HHS) rule that enabled the Centers for Medicare and Medicaid Services (CMS) to audit Medicare Advantage (MA) plans more rigorously. This regulatory rollback follows a legal challenge by Humana, a major insurance company, which raised concerns over increased scrutiny of insurers administering MA plans. The decision complicates ongoing efforts to address issues of overpayments and fraud within the Medicare Advantage program. Medicare Advantage was designed as a private sector alternative to traditional Medicare, aiming to offer more personalized and efficient health coverage through private insurance companies. However, the program has faced criticism due to misaligned incentives, leading to substantial overpayments from the federal government to insurers. Practices such as "upcoding," where insurers exaggerate patients' diagnoses to secure higher payments, and flawed risk-adjustment methodologies are central problems. The risk-adjustment process often involves non-physician personnel conducting health risk assessments, which may not accurately reflect patients' health status, contributing to inflated billing. Improper payments to Medicare Advantage plans amounted to over $19 billion in 2024, with approximately $7.5 billion linked to insurer-conducted health risk assessments. This trend is expected to grow as Medicare Advantage enrollment increases and potentially surpasses traditional Medicare enrollment by 2034. The recent court decision limits CMS’s ability to audit and control these insurer practices effectively, highlighting the need for Congressional action to reform Medicare Advantage payment and oversight mechanisms. Legislative proposals, including Senator Bill Cassidy’s NO UPCODE Act, seek to extend the risk-adjustment period and tighten rules against upcoding, though these measures have yet to advance significantly in Congress. The ruling underscores the ongoing challenges of balancing private insurer administration within federal health programs. Ensuring Medicare Advantage fulfills its potential as a cost-effective and patient-focused alternative requires renewed regulatory frameworks and legislative solutions to prevent abuse and protect taxpayer funds. The decision serves as a call to Congress to enact meaningful reforms that maintain program integrity and sustainability.